As expected, the Moderna CEO appears to be setting up the narrative to sell a brand new round of vaccines when he says that current jabs are likely to be less effective against the new variant.
Stéphane Bancel made the comments in a recent interview with the Financial Times.
It is worth reminding our audience that Moderna’s one and only commercialized product is the Covid-19 vaccine, so this is the company’s bread and butter.
Following the Omicron-specific vaccine, there will likely be an Omicron-specific booster, which will do for the ‘fully vaccinated’ until the new variant emerges around this time next year.
Tell us your thoughts in the Facebook post and share this with your friends.